Mandate

Vinge has advised EQT in connection with the combination with Exeter Property Group

Vinge has advised EQT in connection with the signing of a combination with Exeter Property Group, a global leading real estate investment manager with more than $ 10 billion of assets under management. The total consideration amounts to MUSD 1,870.

Through the transaction, EQT will acquire 100 percent of the Exeter management company and 25 percent of the carried interest in selected existing Exeter funds. Ward Fitzgerald and other Exeter management shareholders will receive their consideration partly in newly issued EQT ordinary shares and partly in cash.

The transaction is subject to customary closing condition and the completion is expected to be carried out at the beginning of the second quarter of 2021.

Vinge’s team mainly consists of Dain Hård Nevonen, Erik Sjöman, Linnéa Sellström, Hampus Olsson and Joel Magnusson, Marcus Glader, Emma Johansson and Johan Wahlbom.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026